Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.66 USD | +3.54% | -4.73% | -31.92% |
May. 14 | Guggenheim Upgrades Amicus Therapeutics to Buy From Neutral With $13 Price Target | MT |
May. 10 | UBS Trims Price Target on Amicus Therapeutics to $19 From $20, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.92% | 2.86B | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.47% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
-1.62% | 11.98B |
- Stock Market
- Equities
- FOLD Stock
- News Amicus Therapeutics, Inc.
- Insider Sell: Amicus Therapeutics